Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Switch to healthier food and drink choices with UK's first ever 'Foodswitch' App

2014-02-13 FoodswitchLaunching today [13th February] FoodSwitchis the first ever smartphone app that enables UK consumers to make healthier and smarter food and drink choices.  Putting consumers in control whilst out shopping, FoodSwitch

will help customers make more informed decisions when purchasing their weekly shop, in turn reducing their risk of ill health through poor diets.

FoodSwitch allows users to scan the barcode of over 80,000 packaged food and drinks sold across major UK supermarkets using their smartphone camera to receive immediate, easy to understand ‘traffic light’ colour-coded nutritional information along with suggested similar, healthier products. It is now easier than ever for consumers to reduce high levels of fat, salt and sugar in their families’ diet. 

FoodSwitch was developed by leading UK nutrition research experts; Consensus Action on Salt and Health (CASH), the Medical Research Council Human Nutrition Research, The British Heart Foundation Health Promotion Research Group, the Nuffield Department of Population Health and the Nuffield Department of Primary Care Health Sciences, University of Oxford, and led by The George Institute for Global Health (TGI). FoodSwitch is further supported by nine UK organisations. 

Susan Jebb, Professor of Diet and Population Health, Nuffield Department of Primary Care Health Sciences, University of Oxford, who was involved in developing the app, commented: "A poor diet is responsible for tens of thousands of premature deaths every year in the UK.  People will be able to use this smartphone technology to swap the foods in their regular shopping basket for healthier options to help themselves and their families to cut their risk of diabetes, heart disease and some cancers."

Links:
Food Switch website
, Facebook, Twitter

Similar stories

Five ways the pandemic has affected routine medical care

Since the beginning of the pandemic, COVID has infected at least a third of the UK population and is estimated to have factored in the deaths of almost 200,000 people in the UK. But critically, COVID has also had a devastating impact on our healthcare systems. While this was expected, new evidence is beginning to reveal the scope of the issue – in particular the effects for people living with long-term health conditions.

Clinical trials for a malaria vaccine start in Mali and Indonesia

Sanaria Inc. announced that two new Phase 2 trials of its pioneering malaria vaccines have started. The first is in 6- to 10-year-old children living in Bancoumana, Mali, a malarious region of West Africa. The second is in Indonesian soldiers based in Sumatra, Indonesia. The soldiers will be deploying for six to nine months this coming August to an intensely malarious district in eastern Indonesia.

Mechanism of expanding bacteria revealed

A new study published in Nature has identified a potential Achilles heel in the protective layers surrounding Gram-negative bacteria that could aid in the development of next-generation antibiotics.

Oxford to receive £7 million to turn bright ideas into global opportunities

The University of Oxford has been awarded more than £7 million, the highest amount of funding given to organisations across the UK, in the latest round of UK Research and Innovation’s (UKRI) Impact Acceleration Account (IAA) funding - aimed at fueling the best, brightest and most disruptive ideas from Uk research institutions.

Discovery of gene involved in chronic pain creates new treatment target

Oxford researchers have discovered a gene that regulates pain sensitisation by amplifying pain signals within the spinal cord, helping them to understand an important mechanism underlying chronic pain in humans and providing a new treatment target.

Oxford's largest ever study into Varicose veins shows need for surgery is linked to genetics

A new international study by Oxford researchers published in Nature Communications establishes for the first time, a critical genetic risk score to predict the likelihood of patients suffering with Varicose veins to require surgery, as well as pointing the way towards potential new therapies.